COVID-19 rebound after Paxlovid treatment likely due to insufficient exposure to the drug
June 22 2022, 08:00
A CDC study of the COVID-19 treatment drug, Paxlovid shows that instances of symptom rebound after treatment may be due to under exposure to the drug
A CDC study of the COVID-19 treatment drug, Paxlovid shows that instances of symptom rebound after treatment may be due to under exposure to the drug
Source:
FOX News